[The possible significance of immunological disorders in the pathogenesis of paroxysmal supraventricular tachycardia in patients with the Wolff-Parkinson-White syndrome].
Perederiĭ
V G
VG
Nikitin
A V
AV
Zemskov
A M
AM
Gusmanov
V A
VA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D004198:Disease Susceptibility; D004206:Disopyramide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007154:Immune System Diseases / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D013951:Thymus Hormones / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology
D000276:Adjuvants, Immunologic; D013951:Thymus Hormones; C032805:thymalin; D004206:Disopyramide
O vozmozhnom znachenii immunologicheskikh narusheniĭ v patogeneze paroksizmal'noĭ nadzheludochkovoĭ takhikardii u bol'nykh s sindromom Vol'fa--Parkinsona--Uaĭta.